Health Catalyst gains access to $100M in new financing

Health Catalyst, a data, analytics and decision support company, closed a series F equity and debt funding round with access to up to $100 million in capital. This brings up the company's value to more than $1 billion.

The company will use the new funds to expand Health Catalyst's technology and services offerings, including the Health Catalyst Data Operating System, a data warehouse and application development platform. It will also support the company's "expansion, already underway, into the life sciences and international markets," said Health Catalyst CEO Dan Burton.

OrbiMed, a healthcare public and private market investment firm, led the equity and debt funding round. Other investors were Sequoia Capital, UPMC Enterprises and Kaiser Permanente Ventures.

More articles on health IT:
Epic named 'Best in KLAS' overall software suite for 9th straight year
How 'big tech' fared last quarter: Earnings from Amazon, Google, Apple & more
Former ONC chief Dr. Karen DeSalvo to advise digital health investment firm: 4 notes

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers